CageTag: Caged Theranostics as a Universal Platform for Nuclear Medicine
Lead Research Organisation:
University of Hull
Department Name: Biomedical Sciences
Abstract
Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
Organisations
Publications
Yang Z
(2023)
Automated sulfur-[18F]fluoride exchange radiolabelling of a prostate specific membrane antigen (PSMA) targeted ligand using the GE FASTlab™ cassette-based platform.
in Reaction chemistry & engineering
| Description | Influence International Atomic Energy Agency position on the future of multimodal medical imaging |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Presentation to Bionow |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Industry/Business |
| Results and Impact | Attended a Bionow Targeted oncology conference with academics, industry representatives and clinical leads. Gave a talk to this diverse audience on new models for radiopharmaceuticals development (using the technology developed in this grant). |
| Year(s) Of Engagement Activity | 2022 |
| Description | Talk to and hosting of visit by Chief Scientific Advisor (Paul Monks) to Department of Business, Energy and Industrial Strategy |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Policymakers/politicians |
| Results and Impact | We engaged with the Department of Business, Energy and Industrial Strategy to host a visit that would inform government about the challenges and issues with radioisotope supply for medical use across the UK. The visit and presentation also indicated potential solutions to these issues (including the science developed in this grant) and influenced the approach to tackling these issues for the benefit of the UK economy and general public (patients). |
| Year(s) Of Engagement Activity | 2022 |